glutathione in cancer treatment Glutathione: Lights and Shadows Patients Glutathione metabolism in cancer progression

p(NIPAAm-co-PAA) (83 mol% NIPAAm, 17 mol% PAA, 37 kDa) copolymers produced hydrogels that released encapsulated VEGF via diffusion over ~7 days at pH 7.4 and over ~3 weeks when pH was lowered to 5 or 6, pH levels consistent with ischemic tissue microenvironments (Garbern et al., in vivo to infarcted myocardium over ~7 days, and improved fractional shortening of and blood flow to the heart, as well as capillary and arteriolar densities as compared to controls (Murry et al., Hybrid materials Combinations of natural and synthetic polymers have also been used to form hybrid hydrogels for controlled drug delivery

The role of glutathione in DNA damage by potassium bromate in vitro

antioxidants retard autoxidation that is caused primarily by radical chain reactions between oxygen and the substrates

It is not measurable